Your browser doesn't support javascript.
loading
Is Phase Angle Useful in Screening for Sarcopenia in Patients with Hematologic Malignancies?
Kasahara, Ryuichi; Fujita, Takaaki; Jinbo, Ryohei; Kubota, Junko; Takano, Aya; Takahashi, Shoko; Ohashi, Yuka; Jinbo, Kazumi; Yamamoto, Yuichi; Kai, Tatsuyuki; Shiga, Yutaka; Kimura, Hideo; Furukawa, Miki; Owari, Mai; Morishita, Shinichiro.
Afiliación
  • Kasahara R; Department of Rehabilitation, Kita-Fukushima Medical Center, Fukushima, Japan.
  • Fujita T; Department of Occupational Therapy, School of Health Sciences, Fukushima Medical University, Fukushima, Japan.
  • Jinbo R; Department of Rehabilitation, Kita-Fukushima Medical Center, Fukushima, Japan.
  • Kubota J; Department of Rehabilitation, Kita-Fukushima Medical Center, Fukushima, Japan.
  • Takano A; Department of Rehabilitation, Kita-Fukushima Medical Center, Fukushima, Japan.
  • Takahashi S; Department of Rehabilitation, Kita-Fukushima Medical Center, Fukushima, Japan.
  • Ohashi Y; Department of Rehabilitation, Kita-Fukushima Medical Center, Fukushima, Japan.
  • Jinbo K; Department of Rehabilitation, Kita-Fukushima Medical Center, Fukushima, Japan.
  • Yamamoto Y; Department of Rehabilitation, Kita-Fukushima Medical Center, Fukushima, Japan.
  • Kai T; Department of Hematology, Kita-Fukushima Medical Center, Fukushima, Japan.
  • Shiga Y; Department of Hematology, Kita-Fukushima Medical Center, Fukushima, Japan.
  • Kimura H; Department of Hematology, Kita-Fukushima Medical Center, Fukushima, Japan.
  • Furukawa M; Department of Hematology, Kita-Fukushima Medical Center, Fukushima, Japan.
  • Owari M; Department of Hematology, Kita-Fukushima Medical Center, Fukushima, Japan.
  • Morishita S; Department of Physical Therapy, School of Health Sciences, Fukushima Medical University, Fukushima, Japan.
Nutr Cancer ; 76(1): 121-127, 2024.
Article en En | MEDLINE | ID: mdl-37987672
The purposes of this study were to investigate the relationship between sarcopenia and phase angle (PhA), and to examine whether PhA cutoff values can be used to identify sarcopenia in patients with hematologic malignancies. The study population comprised 108 patients with hematologic malignancies who were admitted for chemotherapy, and were undergoing rehabilitation for exercise therapy. The diagnostic criteria for sarcopenia were determined according to the Asian Working Group for Sarcopenia 2019. Muscle strength, endurance, and body composition (including PhA), were assessed. Logistic regression and receiver operating characteristic (ROC) curve analyses were performed to investigate associations between sarcopenia and PhA, and to determine cutoff values. Sarcopenia was found in 17.6% of the participants. PhA was significantly associated with sarcopenia (p < 0.01). The areas under the curve were 0.84 for the males and 0.87 for the females, and the cutoff values were 4.75° for the males (sensitivity 69%, specificity 83%) and 3.95° for the females (sensitivity 78%, specificity 85%). Our results suggest that PhA, which can be measured noninvasively, objectively, and rapidly, can be used as a screening tool for sarcopenia in patients with hematologic malignancies.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Hematológicas / Sarcopenia Límite: Female / Humans / Male Idioma: En Revista: Nutr Cancer Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Hematológicas / Sarcopenia Límite: Female / Humans / Male Idioma: En Revista: Nutr Cancer Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos